Research: Intramural and Extramural Jacquelyn Goldberg, JD CIRB Review Board Administrator Clinical Investigations Branch, CTEP Division of Cancer Treatment.

Slides:

Advertisements

Similar presentations

Chiari Surgical Outcomes Trial PI: Bermans J. Iskandar and Timothy George with collaboration from John Kestle ASAP-funded pilot study ASAP-funded pilot.

Advertisements

The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.

Central IRBs An IRB Infoshort June Working Definition  A central IRB is one that serves as IRB of record for all of the sites engaged in a research.

THE UW HEALTH SCIENCES IRB S OVERVIEW PRACTICAL REGULATORY ISSUES IN HUMAN SUBJECTS RESEARCH.

Guideline for Monitoring of Clinical Trials for Cooperative Groups, CCOP Research Bases, and the Clinical Trials Support Unit (CTSU) Lore Lagrone Program.

Multi-Institutional Facilitated IRB Review Philip A. Cola, MA Vice President, Research and Technology University Hospitals Case Medical Center Third Annual.

12 May 2015 ACR TRIAD IMAGE MANAGEMENT SYSTEM NCI CQIE – Centers of Quantitative Imaging Excellence Program NCI Centers of Quantitative Imaging Excellence.

DHMH Institutional Review Board Research, Respect and Responsibility.

Research Protocol ACRIN 6678 Learning About PET/CT Scans: Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?

ANPRM Single IRB Review mandated for multi-site domestic research P. Pearl O’Rourke, M.D. Partners Health Care.

Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.

National Cancer Institute (NCI) Central Institutional Review Board (CIRB) Research Studies UCSF HRPP Submission Process Overview Tuesday, December.

October 19, 2010 Steven Hirschfeld, MD, PhD Julia Slutsman, PhD

Human Subject Protection Judith Birk IRB Health / Behavioral Sciences.

Brookhaven Science Associates U.S. Department of Energy 1 Brookhaven National Laboratory Protocol Compliance Monitoring Darcy Mallon May 7, 2009.

Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.

Central IRBs: Ceding IRB Oversight

CALGB Informational Session June 22, 2007 David Hurd, MD Interim Chair Data Audit Committee.

SERIOUS ADVERSE EVENTS REPORTING Elizabeth Dayag IRB Administrator Naval Medical Center Portsmouth.

Primary Care and Community Outreach Research VCOM Institutional Review Board Jim Mahaney, PhD Associate Dean for Biomedical Affairs, Virginia Campus Past.

Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.

1 Research Subject Registration & Grant Charges Clinical Research Education Series August 29 th, 2006 Marta Sears.

Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.

GCP & ETHICS COMMITTEES Ravi Rengachari Vector Control Research Centre PONDICHERRY.

Minimum Standards and Exemplary Attributes of Clinical Trial Sites S. Gail Eckhardt, MD (Slides prepared by Robin Zon, MD)

H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…

VA Central IRB Annette R. Anderson, MS, RHIA, CIP VA Central IRB Administrator HRPP 101, September 2010.

The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.

Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.

SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Unresectable Malignant Peripheral Nerve Sheath Tumors.

SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.

The Research Subject Advocate (RSA). Pictured, left to right: Andrea Saltzman, RN; Enrico Cagliero, MD; Debi Dunkless.

The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.

NCI Clinical Trials Reporting Program CTRP User Meeting October 6, 2010.

LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

CTRP User Call November 13, 2013 Gene Kraus CTRP Program Director.

Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.

Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.

VA Central IRB Annette R. Anderson, MS, RHIA, CIP VA Central IRB Administrator Local Accountability Meeting June 2011.

ROAD MAP: Getting a Cancer Study Done at Jefferson Sylvia O’Neill, MD Associate Director of Regulatory Affairs and Quality Assurance Clinical Trials Office.

Research Orientation to SCCA. What is the SCCA? The SCCA brings together the outstanding adult and pediatric oncology patient care services of three world-

Investigational Devices and Humanitarian Use Devices June 2007.

The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.

Updates in Research Protections Karen Allen Director, Research Protections Office of Research November

Data and Safety Monitoring Board Responsibilities Review routine reports created by ACRIN Biostatistics Center: Mid-Year and Year-End Updates. Routine.

Understanding Clinical Trials – Part 2 Georgianne Arnold, MD Professor of Pediatrics University of Pittsburgh Medical Center Pittsburgh Children’s Hospital.

Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.

CTEP Visiting Physician Externship Coordinator: Igor Espinoza-Delgado, M.D. NCI CTEP Investigational Drug Branch

The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.

NCI Clinical Trials Reporting Program CTRP User Meeting June 6, 2012 Gene Kraus CTRP Program Director.

VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.

ROAD MAP: Getting a Cancer Study Done at Jefferson Sylvia O’Neill, MD Associate Director of Regulatory Affairs and Quality Assurance Clinical Trials Office.

1 MARCH 2012 Regulatory Documents & the CTSU.

Opening An ETCTN Study at Your Site August Scope of this Presentation  This presentation applies to all sites which will be participating on.

ROAD MAP: Getting a Cancer Study Done at Jefferson Meghan Wakefield,RN,CCRP Senior Director of Clinical Trials Office Clinical Research Organization.

IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.

Multi-site Research - Central/Single IRBs - Data sharing questions P. Pearl O’Rourke, MD Partners HealthCare October 26, 2015.

Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.

Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.

University of Central Florida Office of Research & Commercialization

What is a Data and Safety Monitoring Plan and how do I get one?

University of Central Florida Office of Research & Commercialization

ARCADIA Coordinator Webinar

Preparing for NIH’s sIRB Review Requirements

SERIOUS ADVERSE EVENTS REPORTING

MAINTAINING THE INVESTIGATOR’S STUDY FILE

TRTO (Translational Research Trials Office)

Changes to the Common Rule and Single IRB (sIRB)

IRB Harmonization 2016 Review

CTSA27 So you want COMIRB to be your sIRB: What you need to know.

Presentation transcript:

Research: Intramural and Extramural Jacquelyn Goldberg, JD CIRB Review Board Administrator Clinical Investigations Branch, CTEP Division of Cancer Treatment & Diagnosis The NCI’s Central IRB Initiative June 26, 2007 Clinical Trials Break Out Session

2 Overview CIRB Initiative is a program which enables IRB review to take place quickly at the local site while maintaining a high degree of human subject protection 2 Central Boards exist (adult and peds) All phase adult 3 Cooperative Group trials and all COG trials receive review and approval prior to being made available to investigators for patient enrollment

3 How does the NCI CIRB model work? NCI/CTEP approves pending CIRB approval CIRB approves protocol NCI sends Group final approval Local investigator is notified of protocol via – Routine Group activation announcement – CIRB bi-monthly

4 If the local investigator decides to open protocol, –OPTION 1: Investigator or CRA downloads the completed application, protocol and consent from the CIRB website and submits documents to local IRB; (LIRB then downloads confidential documents) –OPTION 2: PI/CRA downloads all the documents and submits them to the LIRB How does the NCI CIRB model work ?

5 Local chair/subcommittee reviews for local concerns and decides whether to approve (“facilitated review”) If LIRB accepts, they notify CIRB. The CIRB becomes the IRB of record. It handles amendments, continuing reviews, adverse events etc. If LIRB does not accept, LIRB can decide to review the protocol themselves as per their own local procedures. How does the NCI CIRB model work ?

6 CIRB and LIRB share regulatory responsibilities –The CIRB’s primary function is initial and continuing review of protocols –The local institution’s primary function is consideration of local context and oversight of local performance

7 CIRB review occurs BEFORE the protocol is distributed nationally; Board has authority to make changes in the protocol (unlike local Boards which can only accept or reject these trials) Extricates Board review process from local institutional politics Protocols are reviewed by sophisticated patient advocates and cancer experts Benefits to Research Participants

8 Benefits to Local Investigators/CRAs No advance preparation for IRB review at the local site—no IRB application to complete, just download the IRB packet from the CIRB website No waiting for the next meeting of the full board, therefore investigators can enroll patients sooner CIRB becomes IRB of record, no need to submit continuing reviews, amendments or AE reports (except for AEs at local site) to the LIRB or the CIRB

9 Total studies presently on menu Adult – 98 Pediatric – 46 –Total 144 Studies open to accrual Adult – 64 Pediatric – 42 –Total 106 Current as of 05/10/2007 Studies available for facilitated review currently on CIRB menu

10 1Albert Einstein Cancer Research Center 2 Arthur G. James Cancer Hospital & Richard J. Solove Research Institute 3 Cancer Center - University of Virginia, Health Sciences Center 4Case Comprehensive Cancer Center 5Yale Cancer Center 6Comprehensive Cancer Center of Wake Forest University 7Duke Comprehensive Cancer Center 8Eppley Cancer Center 9Fox Chase Cancer Center 10Fred Hutchinson Cancer Research Center 11Herbert Irving Comprehensive Cancer Center 12Huntsman Cancer Institute 13Indiana University Cancer Center 14Jonsson Comprehensive Cancer Center 15Kimmel Cancer Center 16Lombardi Comprehensive Cancer Center 17Mayo Clinic Cancer Center (Mayo Health System) 18Norris Cotton Cancer Center 19OHSU Cancer Institute 20Siteman Cancer Center 21The Cancer Institute of New Jersey 22The Holden Comprehensive Cancer Center 23The Sidney Kimmel Comprehensive Cancer Center 24UAB Comprehensive Cancer Center 25UCSF Comprehensive Cancer Center 26UNC Lineberger Comprehensive Cancer Center 27University of Colorado Cancer Center 28University of Michigan Comprehensive Cancer Center 29University of Pittsburgh Cancer Institute 30University of Wisconsin Comprehensive Cancer Center 31UNM Cancer Research & Treatment Center 32USC/Norris Comprehensive Cancer Center 33University of Arizona – Arizona Cancer Center Current as of 05/10/2007 NCI Designated Cancer Centers

11 NCI CIRB Initiative: 6 Easy Steps to Join Modify institution’s FWA to include the CIRB and sign authorization agreement Create a local IRB SOP for utilizing the CIRB Determine the composition of the LIRB subcommittee Notify local investigators of the new process Copy the CIRB on the notification (which will show that the process is complete) Provide CIRB with contact information for LIRB and PI to establish website access and facilitate communication

12 Contact the NCI CIRB CIRB Toll-free Number: Fax Number: Mailing address: NCI CIRB C/O The EMMES Corporation 401 N. Washington Street, Suite 700 Rockville, MD 20850